LCN2 and ovarian cancer: The aim of this study was to determine the concentrations of irisin, chemerin, lipocalin-2 and omentin-1 in the serum and peritoneal fluid of patients with ovarian cancer, as well as in the serum of patients with benign ovarian lesions.